Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.64 |
| ▸ | BCHE | P06276 | 2/20 | 0.64 |
| ▸ | LTA4H | P09960 | 2/20 | 0.55 |
| ▸ | CCR3 | P51677 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1138416 | 0.91 | ACHE (0.76) | ACHEBCHELTA4HCCR3 | |
| Hydrochloric Acid SCHEMBL3156661 | 0.90 | ACHE (0.77) | ACHEBCHELTA4HCCR3 | |
| SCHEMBL7695896 | 0.85 | LTA4H (0.65) | ACHEBCHELTA4HCCR3CXCR4 | |
| SCHEMBL6823142 | 0.83 | CCR3 (0.58) | ACHEBCHELTA4HCCR3CXCR4 | |
| SCHEMBL8340597 | 0.83 | CCR3 (0.58) | ACHEBCHELTA4HCCR3CXCR4 | |
| SCHEMBL6312697 | 0.83 | CXCR4 (0.59) | ACHEBCHECCR3CXCR4 | |
| SCHEMBL994263 | 0.82 | FUCA1 (0.51) | ACHEBCHE | |
| SCHEMBL7853462 | 0.81 | ACHE (0.74) | ACHEBCHECCR3GAA | |
| Oxalic Acid SCHEMBL10461399 | 0.81 | CYP2D6 (0.66) | ACHEBCHECCR3CXCR4GAA | |
| SCHEMBL12513916 | 0.80 | CCR3 (0.58) | ACHEBCHECCR3CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5134147-A | Antipsychotic agents | ADIR ET COMPAGNIE (FR) | 1992-07-28 | — | — | US | disclosed |
| US-5100902-A | Dopamine and Serotonin Antagonists, Antipsychotic Agents | ADIR ET COMPAGNIE (FR) | 1992-03-31 | — | — | US | disclosed |